Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Chembl292963
2. (r)-minalrestat
3. Schembl9388567
4. Dtxsid50869780
5. Zinc597385
6. Bdbm50038843
7. Db07450
8. Q27096670
9. (4r)-2-(4-bromo-2-fluorobenzyl)-6-fluoro-1h,2''h,5''h-spiro[isoquinoline-4,3''-pyrrolidine]-1,2'',3,5''(2h)-tetrone
10. (4r)-2-(4-bromo-2-fluorobenzyl)-6-fluoro-1h,2'h,5'h-spiro[isoquinoline-4,3'-pyrrolidine]-1,2',3,5'(2h)-tetrone
11. (4r)-2-[(4-bromo-2-fluorophenyl)methyl]-6-fluoro-2,3-dihydro-1h-spiro[isoquinoline-4,3''-pyrrolidine]-1,2'',3,5''-tetrone
12. 129688-57-9
13. 2-(4-bromo-2-fluorobenzyl)-6-fluoro-1h,2''h,5''h-spiro[isoquinoline-4,3''-pyrrolidine]-1,2'',3,5''(2h)-tetrone
14. 2-(4-bromo-2-fluorobenzyl)-6-fluorospiro[1,2,3,4-tetrahydroisoquinoline-4,3''-(tetrahydro-1''h-pyrrole)]-1,2'',3,5''-tetraone
15. 2[4-bromo-2-fluorophenyl)methyl]-6-fluorospiro[isoquinoline-4-(1h),3''-pyrrolidine]-1,2'',3,5''(2h)-tetrone
16. Spiro[isoquinoline-4(1h),3'-pyrrolidine]-1,2',3,5'(2h)-tetrone, 2-[(4-bromo-2-fluorophenyl)methyl]-6-fluoro-, (3's)-
| Molecular Weight | 449.2 g/mol |
|---|---|
| Molecular Formula | C19H11BrF2N2O4 |
| XLogP3 | 2.1 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 2 |
| Exact Mass | 447.98703 g/mol |
| Monoisotopic Mass | 447.98703 g/mol |
| Topological Polar Surface Area | 83.6 Ų |
| Heavy Atom Count | 28 |
| Formal Charge | 0 |
| Complexity | 735 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
53
PharmaCompass offers a list of Chembl292963 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Chembl292963 manufacturer or Chembl292963 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Chembl292963 manufacturer or Chembl292963 supplier.
PharmaCompass also assists you with knowing the Chembl292963 API Price utilized in the formulation of products. Chembl292963 API Price is not always fixed or binding as the Chembl292963 Price is obtained through a variety of data sources. The Chembl292963 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A BFI manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of BFI, including repackagers and relabelers. The FDA regulates BFI manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. BFI API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A BFI supplier is an individual or a company that provides BFI active pharmaceutical ingredient (API) or BFI finished formulations upon request. The BFI suppliers may include BFI API manufacturers, exporters, distributors and traders.
BFI Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of BFI GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right BFI GMP manufacturer or BFI GMP API supplier for your needs.
A BFI CoA (Certificate of Analysis) is a formal document that attests to BFI's compliance with BFI specifications and serves as a tool for batch-level quality control.
BFI CoA mostly includes findings from lab analyses of a specific batch. For each BFI CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
BFI may be tested according to a variety of international standards, such as European Pharmacopoeia (BFI EP), BFI JP (Japanese Pharmacopeia) and the US Pharmacopoeia (BFI USP).
